Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 12, 2012 - Issue 10
Submit an article Journal homepage
3,073
Views
54
CrossRef citations to date
0
Altmetric
Theme: Nervous System Neoplasm - Review

Melanoma brain metastasis: overview of current management and emerging targeted therapies

Ekokobe Fonkem Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurosurgery, Scott and White Hospital, Texas A&M College of Medicine, Temple, TX, USA; Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurosurgery, Scott and White Hospital, Texas A&M College of Medicine, Temple, TX, USA
,
Erik J Uhlmann Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
,
Scott R Floyd Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
,
Anand Mahadevan Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
,
Ekkehard Kasper Department of Surgery (Division of Neurosurgery), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Surgery (Division of Neurosurgery), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
,
Omar Eton Department of Medicine (Division of Hematology/Oncology), Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Medicine (Division of Hematology/Oncology), Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
&
Eric T Wong Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. [email protected]
 show all
Pages 1207-1215 | Published online: 09 Jan 2014

Citations (54)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Mudit Chowdhary, Kirtesh R Patel, Hasan H Danish, David H Lawson & Mohammad K Khan. (2016) BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy. OncoTargets and Therapy 9, pages 7149-7159.
Read now
Claire Roddie & Karl S Peggs. (2014) Emerging options for the treatment of melanoma – focus on ipilimumab. ImmunoTargets and Therapy 3, pages 67-78.
Read now
Jiezhong Chen, Renfu Shao, Xu Dong Zhang & Chen Chen. (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine 8, pages 2677-2688.
Read now
George Klironomos & Mark Bernstein. (2013) Salvage stereotactic radiosurgery for brain metastases. Expert Review of Neurotherapeutics 13:11, pages 1285-1295.
Read now
Anna S Berghoff & Matthias Preusser. (2013) Biology in prevention and treatment of brain metastases. Expert Review of Anticancer Therapy 13:11, pages 1339-1348.
Read now

Articles from other publishers (49)

Herbert B. Newton, Ramya Tadipatri & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging 25 37 .
Erika Santos Horta & Tobias Walbert. 2022. Cancer Metastasis Through the Lymphovascular System. Cancer Metastasis Through the Lymphovascular System 559 565 .
K. A. Kessel, A. Deichl, J. Gempt, B. Meyer, C. Posch, C. Diehl, C. Zimmer & S. E. Combs. (2021) Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA. Clinical and Translational Oncology 23:10, pages 2020-2029.
Crossref
Rolina K. Al-Wassia & Omar Iskanderani. (2021) Stereotactic Radiosurgery (SRS) experience on brain metastases: A 3-year retrospective study at King Abdulaziz University Hospital. Saudi Journal of Biological Sciences 28:9, pages 5042-5047.
Crossref
Muhammad Khan, Tao Zheng, Zhihong Zhao, Sumbal Arooj & Guixiang Liao. (2021) Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis. Frontiers in Oncology 10.
Crossref
Trude G. Simonsen, Jon-Vidar Gaustad & Einar K. Rofstad. (2020) Bevacizumab treatment of meningeal melanoma metastases. Journal of Translational Medicine 18:1.
Crossref
Marra Jai Aghajani, Adam Cooper, Helen McGuire, Thomas Jeffries, Jawad Saab, Kasim Ismail, Paul de Souza, Victoria Bray, Barbara Fazekas de St Groth, Navin Niles & Tara Laurine Roberts. (2019) Pembrolizumab for anaplastic thyroid cancer: a case study. Cancer Immunology, Immunotherapy 68:12, pages 1921-1934.
Crossref
Hussein Akil, Jacques Rouanet, Claire Viallard, Sophie Besse, Philippe Auzeloux, Jean-Michel Chezal, Elisabeth Miot-Noirault, Mercedes Quintana & Françoise Degoul. (2019) Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms. Translational Oncology 12:11, pages 1442-1452.
Crossref
Kevin Diao, Shelly X. Bian, David M. Routman, Cheng Yu, Jason C. Ye, Naveed A. Wagle, Michael K. Wong, Gabriel Zada & Eric L. Chang. (2018) Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity. Journal of Neuro-Oncology 139:2, pages 421-429.
Crossref
Anna M. Rose, Utsav K. Radia, Rong Luo, Helen Kalirai, Channa N. Jayasena, Philip Luthert, Sarah E. Coupland & Geoffrey E. Rose. (2018) Multiple primary malignancies and prolonged survival in a patient with widespread metastatic cutaneous melanoma. Melanoma Research 28:2, pages 163-166.
Crossref
Joonho Byun, Eun Suk Park, Seok Ho Hong, Young Hyun Cho, Young-Hoon Kim, Chang Jin Kim, Jeong Hoon Kim & Seungjoo Lee. (2018) Clinical outcomes of primary intracranial malignant melanoma and metastatic intracranial malignant melanoma. Clinical Neurology and Neurosurgery 164, pages 32-38.
Crossref
Jin-cheng Song, Xiao-lei Ding, Xiu-hua Sun, Mohammed Safi & Juan Tian. (2017) Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy. Medicine 96:50, pages e9278.
Crossref
Manisha Singh, Christina Vianden, Mark J. Cantwell, Zhimin Dai, Zhilan Xiao, Meenu Sharma, Hiep Khong, Ashvin R. Jaiswal, Faisal Faak, Yared Hailemichael, L. M. E. Janssen, Uddalak Bharadwaj, Michael A. Curran, Adi Diab, Roland L. Bassett, David J. Tweardy, Patrick Hwu & Willem W. Overwijk. (2017) Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nature Communications 8:1.
Crossref
Federico Pessina, Pierina Navarria, Stefano Tomatis, Luca Cozzi, Ciro Franzese, Lorenza Di Guardo, Anna Maria Ascolese, Giacomo Reggiori, Davide Franceschini, Michele Del Vecchio, Lorenzo Bello & Marta Scorsetti. (2017) Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. World Neurosurgery 105, pages 184-190.
Crossref
Wanlu DuIvan SeahOumaima BougazzoulGiHun ChoiKatrina MeethMarcus W. BosenbergHiroaki WakimotoDavid FisherKhalid Shah. (2017) Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas. Proceedings of the National Academy of Sciences 114:30.
Crossref
Jacob Pitcovski, Ehud Shahar, Elina Aizenshtein & Raphael Gorodetsky. (2017) Melanoma antigens and related immunological markers. Critical Reviews in Oncology/Hematology 115, pages 36-49.
Crossref
Russell Maxwell, Tomas Garzon‐Muvdi, Evan J. Lipson, William H. Sharfman, Chetan Bettegowda, Kristin J. Redmond, Lawrence R. Kleinberg, Xiaobu Ye & Michael Lim. (2017) BRAF ‐V600 mutational status affects recurrence patterns of melanoma brain metastasis . International Journal of Cancer 140:12, pages 2716-2727.
Crossref
Keisuke Imafuku, Koji Yoshino, Kei Yamaguchi, Satoshi Tsuboi, Kuniaki Ohara & Hiroo Hata. (2017) Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients. Case Reports in Oncology 10:1, pages 290-295.
Crossref
Rui Feng, Eric K. Oermann, Raj Shrivastava, Ariel Gold, Brian T. Collins, Douglas Kondziolka & Sean P. Collins. (2017) Stereotactic Radiosurgery for Melanoma Brain Metastases: A Comprehensive Clinical Case Series. World Neurosurgery 100, pages 297-304.
Crossref
Nour Kibbi & Harriet Kluger. (2016) The Treatment of Melanoma Brain Metastases. Current Oncology Reports 18:12.
Crossref
D. Franceschini, C. Franzese, P. Navarria, A.M. Ascolese, F. De Rose, M. Del Vecchio, A. Santoro & M. Scorsetti. (2016) Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?. Cancer Treatment Reviews 50, pages 1-8.
Crossref
Clarissa Ribeiro Reily Rocha, Gustavo Satoru Kajitani, Annabel Quinet, Rodrigo Soares Fortunato & Carlos Frederico Martins Menck. (2016) NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Oncotarget 7:30, pages 48081-48092.
Crossref
R. Rauschenberg, G. Tabatabai, E. G. C. Troost, M. Garzarolli, S. Beissert & F. Meier. (2016) Hirnmetastasen des malignen MelanomsMelanoma brain metastases. Der Hautarzt 67:7, pages 536-543.
Crossref
Trude G. Simonsen, Jon-Vidar Gaustad & Einar K. Rofstad. (2016) Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma. Translational Oncology 9:3, pages 211-218.
Crossref
Ziqiang Zhu, Wei Liu & Vladimir Gotlieb. (2016) The rapidly evolving therapies for advanced melanoma—Towards immunotherapy, molecular targeted therapy, and beyond. Critical Reviews in Oncology/Hematology 99, pages 91-99.
Crossref
M.A. Hayat. 2016. Brain Metastases from Primary Tumors, Volume 3. Brain Metastases from Primary Tumors, Volume 3 3 20 .
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging 23 33 .
Trude G. Simonsen, Jon-Vidar Gaustad & Einar K. Rofstad. (2015) Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Thankamma Ajithkumar, Christine Parkinson, Kate Fife, Pippa Corrie & Sarah Jefferies. (2015) Evolving treatment options for melanoma brain metastases. The Lancet Oncology 16:13, pages e486-e497.
Crossref
C. Thallinger, G. Prager, H. Ringl & C. Zielinski. (2015) Abscopal-Effekt in der Therapie des malignen MelanomsAbscopal effect in the treatment of malignant melanoma. Der Hautarzt 66:7, pages 545-548.
Crossref
CHRISTIAN OSTHEIMER, CAROLINE BORMANN, ECKHARD FIEDLER, WOLFGANG MARSCH & DIRK VORDERMARK. (2015) Malignant melanoma brain metastases: Treatment results and prognostic factors - a single-center retrospective study. International Journal of Oncology 46:6, pages 2439-2448.
Crossref
M. Hecht, L. Zimmer, C. Loquai, C. Weishaupt, R. Gutzmer, B. Schuster, S. Gleisner, B. Schulze, S.M. Goldinger, C. Berking, A. Forschner, P. Clemens, G. Grabenbauer, T. Müller-Brenne, J. Bauch, H.T. Eich, S. Grabbe, D. Schadendorf, G. Schuler, P. Keikavoussi, S. Semrau, R. Fietkau, L.V. Distel & L. Heinzerling. (2015) Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients. Annals of Oncology 26:6, pages 1238-1244.
Crossref
Tulasi Gummadi, Ben Y. Zhang, Sara Valpione, Chul Kim, Lisa A. Kottschade, Rajendar K. Mittapalli, Vanna Chiarion-Sileni, Jacopo Pigozzo, William F. Elmquist & Arkadiusz Z. Dudek. (2015) Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases. Melanoma Research 25:1, pages 75-79.
Crossref
É. Le Rhun, C. Mateus, L. Mortier, F. Dhermain, B. Guillot, J.-J. Grob, C. Lebbe, M. Thomas, T. Jouary, M.-T. Leccia & C. Robert. (2015) Traitement systémique des métastases cérébrales de mélanome. Cancer/Radiothérapie 19:1, pages 48-54.
Crossref
É. Le Rhun, F. Dhermain, G. Noël, N. Reyns, A. Carpentier, E. Mandonnet, S. Taillibert & P. Metellus. (2015) Recommandations de l’Anocef pour la prise en charge des métastases cérébrales. Cancer/Radiothérapie 19:1, pages 66-71.
Crossref
. 2015. Facharzt Hämatologie Onkologie. Facharzt Hämatologie Onkologie e1 e79 .
Herbert B. Newton & Jose J. Otero. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors 29 43 .
Karim Tazi, Amanda Hathaway, Cody Chiuzan & Keisuke Shirai. (2014) Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery. Cancer Medicine 4:1, pages 1-6.
Crossref
Francis Vekeman, Michel Cloutier, Sander Yermakov, Mayur M. Amonkar, Bhakti Arondekar & Mei S. Duh. (2014) Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population. Melanoma Research 24:6, pages 602-610.
Crossref
L. Peuvrel, M. Saint-Jean, G. Quéreux, A. Brocard, A. Khammari, A. C. Knol & B. Dréno. (2014) Incidence and characteristics of melanoma brain metastases developing during treatment with vemurafenib. Journal of Neuro-Oncology 120:1, pages 147-154.
Crossref
Sara D. Robinson, Joyce A. O'Shaughnessy, C. Lance Cowey & Kartik Konduri. (2014) BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib. Lung Cancer 85:2, pages 326-330.
Crossref
Inderjit Daphu, Sindre Horn, Daniel Stieber, Jobin Varughese, Endy Spriet, Hege Dale, Kai Skaftnesmo, Rolf Bjerkvig & Frits Thorsen. (2014) In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways. International Journal of Molecular Sciences 15:5, pages 8773-8794.
Crossref
Stephanie Du Four, Angela Hong, Matthew Chan, Michail Charakidis, Johnny Duerinck, Sofie Wilgenhof, Wei Wang, Linda Feng, Alex Michotte, Meena Okera, Brindha Shivalingam, Gerald Fogarty, Richard Kefford & Bart Neyns. (2014) Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients. Case Reports in Oncological Medicine 2014, pages 1-6.
Crossref
James E. Jackson, Bryan H. Burmeister, Elizabeth A. Burmeister, Matthew C. Foote, Janine M. Thomas, Janelle A. Meakin & B. Mark Smithers. (2013) Melanoma brain metastases: the impact of nodal disease. Clinical & Experimental Metastasis 31:1, pages 81-85.
Crossref
Lucio Tentori, Pedro Miguel Lacal & Grazia Graziani. (2013) Challenging resistance mechanisms to therapies for metastatic melanoma. Trends in Pharmacological Sciences 34:12, pages 656-666.
Crossref
Jack Murrell & Ruth Board. (2013) The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: Opportunities and unanswered questions. Cancer Treatment Reviews 39:8, pages 833-838.
Crossref
Takafumi Kamiya, Aaron K. Mobley & Menashe Bar-Eli. (2013) Crossing the junction in the gap of melanoma brain metastasis. Pigment Cell & Melanoma Research 26:4, pages 435-437.
Crossref
Sarah Nicholas, Dimitrios Mathios, Christopher Jackson & Michael Lim. (2013) Metastatic Melanoma to the Brain: Surgery and Radiation Is Still the Standard of Care. Current Treatment Options in Oncology 14:2, pages 264-279.
Crossref
Melinda B. Chu, Mark J. Fesler, Eric S. Armbrecht, Scott W. Fosko, Eddy Hsueh & John M. Richart. (2013) High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases. Chemotherapy Research and Practice 2013, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.